145 related articles for article (PubMed ID: 26929618)
21. The prevalence of chronic obstructive pulmonary disease in Riyadh, Saudi Arabia: a BOLD study.
Al Ghobain M; Alhamad EH; Alorainy HS; Al Kassimi F; Lababidi H; Al-Hajjaj MS
Int J Tuberc Lung Dis; 2015 Oct; 19(10):1252-7. PubMed ID: 26459542
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of chronic obstructive pulmonary disease and rhinitis in northern Greece.
Sichletidis L; Tsiotsios I; Gavriilidis A; Chloros D; Kottakis I; Daskalopoulou E; Konstantinidis T
Respiration; 2005; 72(3):270-7. PubMed ID: 15942296
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of chronic obstructive pulmonary disease and associated risk factors in Uganda (FRESH AIR Uganda): a prospective cross-sectional observational study.
van Gemert F; Kirenga B; Chavannes N; Kamya M; Luzige S; Musinguzi P; Turyagaruka J; Jones R; Tsiligianni I; Williams S; de Jong C; van der Molen T
Lancet Glob Health; 2015 Jan; 3(1):e44-51. PubMed ID: 25539969
[TBL] [Abstract][Full Text] [Related]
24. Impact of chronic obstructive pulmonary disease (COPD) on patient's life and his family.
Kupryś-Lipińska I; Kuna P
Pneumonol Alergol Pol; 2014; 82(2):82-95. PubMed ID: 24615192
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of smoking in a psychiatric hospital and its relationship with respiratory symptoms and the prevalence of COPD.
Lores L; Monje A; Bergada M; Arellano E; Rodríguez-Larrea J; Miravitlles M
Int J Chron Obstruct Pulmon Dis; 2018; 13():2797-2804. PubMed ID: 30233170
[TBL] [Abstract][Full Text] [Related]
26. Relationship between chronic obstructive pulmonary disease and subclinical coronary artery disease in long-term smokers.
Rasmussen T; Køber L; Pedersen JH; Dirksen A; Thomsen LH; Stender S; Brodersen J; Groen J; Ashraf H; Kofoed KF
Eur Heart J Cardiovasc Imaging; 2013 Dec; 14(12):1159-66. PubMed ID: 23639550
[TBL] [Abstract][Full Text] [Related]
27. Smoking duration, respiratory symptoms, and COPD in adults aged ≥45 years with a smoking history.
Liu Y; Pleasants RA; Croft JB; Wheaton AG; Heidari K; Malarcher AM; Ohar JA; Kraft M; Mannino DM; Strange C
Int J Chron Obstruct Pulmon Dis; 2015; 10():1409-16. PubMed ID: 26229460
[TBL] [Abstract][Full Text] [Related]
28. The prevalence of chronic obstructive pulmonary disease in Maastricht, the Netherlands.
Vanfleteren LE; Franssen FM; Wesseling G; Wouters EF
Respir Med; 2012 Jun; 106(6):871-4. PubMed ID: 22349067
[TBL] [Abstract][Full Text] [Related]
29. Characteristics of Patients with Chronic Obstructive Pulmonary Disease at the First Visit to a Pulmonary Medical Center in Korea: The KOrea COpd Subgroup Study Team Cohort.
Lee JY; Chon GR; Rhee CK; Kim DK; Yoon HK; Lee JH; Yoo KH; Lee SH; Lee SY; Kim TE; Kim TH; Park YB; Hwang YI; Kim YS; Jung KS
J Korean Med Sci; 2016 Apr; 31(4):553-60. PubMed ID: 27051239
[TBL] [Abstract][Full Text] [Related]
30. Incidence and determinants of moderate COPD (GOLD II) in male smokers aged 40-65 years: 5-year follow up.
Geijer RM; Sachs AP; Verheij TJ; Salomé PL; Lammers JW; Hoes AW
Br J Gen Pract; 2006 Sep; 56(530):656-61. PubMed ID: 16953996
[TBL] [Abstract][Full Text] [Related]
31. Occupational exposures and COPD: an ecological analysis of international data.
Blanc PD; Menezes AM; Plana E; Mannino DM; Hallal PC; Toren K; Eisner MD; Zock JP
Eur Respir J; 2009 Feb; 33(2):298-304. PubMed ID: 19010980
[TBL] [Abstract][Full Text] [Related]
32. Do we need tailored smoking cessation interventions for smokers with COPD? A comparative study of smokers with and without COPD regarding factors associated with tobacco smoking.
van Eerd EA; van Rossem CR; Spigt MG; Wesseling G; van Schayck OC; Kotz D
Respiration; 2015; 90(3):211-9. PubMed ID: 26022403
[TBL] [Abstract][Full Text] [Related]
33. Clinical characteristics, treatment patterns, and socio-economic burden of COPD in Bulgaria.
Kamusheva M; Dimitrova M; van Boven JF; Postma MJ; van der Molen T; Kocks JW; Mitov K; Doneva M; Petrova D; Georgiev O; Petkova V; Petrova G
J Med Econ; 2017 May; 20(5):503-509. PubMed ID: 28058859
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of chronic obstructive pulmonary disease in Fez, Morocco: results from the BOLD study.
El Rhazi K; Nejjari C; BenJelloun MC; El Biaze M; Attassi M; Garcia-Larsen V
Int J Tuberc Lung Dis; 2016 Jan; 20(1):136-41. PubMed ID: 26688540
[TBL] [Abstract][Full Text] [Related]
35. Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking Report from the Obstructive Lung Disease in Northern Sweden Studies.
Lindberg A; Bjerg A; Rönmark E; Larsson LG; Lundbäck B
Respir Med; 2006 Feb; 100(2):264-72. PubMed ID: 15975774
[TBL] [Abstract][Full Text] [Related]
36. The cost of COPD exacerbations: a university hospital--based study in Greece.
Geitona M; Hatzikou M; Steiropoulos P; Alexopoulos EC; Bouros D
Respir Med; 2011 Mar; 105(3):402-9. PubMed ID: 20970310
[TBL] [Abstract][Full Text] [Related]
37. Prevalence and risk factors of chronic obstructive pulmonary disease (COPD) in Dhaka city population.
Islam MS; Hossain MM; Pasha MM; Azad AK; Murshed KM
Mymensingh Med J; 2013 Jul; 22(3):547-51. PubMed ID: 23982547
[TBL] [Abstract][Full Text] [Related]
38. The occurrence of chronic obstructive pulmonary disease (COPD) in cigarette smoking families.
Kałucka S
Przegl Lek; 2006; 63(10):848-57. PubMed ID: 17288170
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and global initiative for chronic obstructive lung disease group distribution of chronic obstructive pulmonary disease detected by preoperative pulmonary function test.
Choi SM; Lee J; Park YS; Lee CH; Lee SM; Yim JJ; Kim YW; Han SK; Yoo CG
PLoS One; 2015; 10(1):e0115787. PubMed ID: 25625286
[TBL] [Abstract][Full Text] [Related]
40. Comorbidity in chronic obstructive pulmonary disease. Related to disease severity?
Echave-Sustaeta JM; Comeche Casanova L; Cosio BG; Soler-Cataluña JJ; Garcia-Lujan R; Ribera X
Int J Chron Obstruct Pulmon Dis; 2014; 9():1307-14. PubMed ID: 25429213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
